Natco Pharma approves investment up to ₹1,400 crore in wholly-owned subsidiary in South Africa
Natco Pharma board has approved increasing stake in Adcock Ingram Holdings to 49%
open_in_new
open_in_new
Read Full Article on Hindu BusinessLine
Original Article
Published on Hindu BusinessLine
● Neutral
Source: Hindu BusinessLine
open_in_new